Hard Brexit: Liability Risk for Carriers
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Despite current progress, there is still a risk that the United Kingdom (UK) will leave the European Union (EU) without an agreement; a so-called "Hard Brexit". Carriers should be prepared. There is an interesting article on this subject from the law firm Arnecke Sibeth Dabelstein.
In the case of a "Hard Brexit", the duty-free trade status of the United Kingdom with the EU Member States would be lifted. As a result, customs declarations would be required for imports and exports and duties will be collected.
In any event, import and export delays are to be expected, which may also have an impact on supply and freight contracts.
The law firm points out that "EU carriers are liable under Article 17(1) of the Convention on the Contract for the International Carriage of Goods by Road (CMR) for damages caused by delay in delivery". With regard to the delays to be feared, "it would be difficult for them to rely on the liability exemption under Article 17(2) of the CMR, which holds that a carrier's circumstances were unavoidable and unpreventable ".
In its commentary, the law firm does not exclude the possibility that a Brexit without an agreement "would increase liability risks for EU carriers and freight forwarders". Before carrying out cross-border transports, they recommend "to make clear agreements with senders in order to clarify that import and export customs clearance delays are expected for an unforeseeable duration. Further, carriers should request instructions from senders in accordance with Article 14 of the CMR to reduce their liability risk."
Related GMP News
12.05.2026European GDP Association Developments January through April 2026
12.05.2026How Are Service Providers Qualified in a GDP Environment?
12.05.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 3
11.05.2026European GDP Association Developments January through April 2026
21.04.2026Implementation of GDP for Pharmaceutical Products in Hong Kong
21.04.2026China's NMPA: Guiding Opinions & Q&A on Standardising Modern Pharmaceutical Logistics


